Urinary Incontinence Treatment Devices Market to Reach over US$ 3.65 Bn by 2025

The global urinary incontinence treatment devices market is driven by high prevalence and rapid increase in incidence of urinary incontinence across the globe. The global market was valued over US$ 1.97 Bn in 2016 and is projected to expand at a CAGR of over 7.0% from 2017 to 2025 to reach US$ 3.65 Bn by 2025. High growth of the market is attributed to significant adoption, easy availability of electrical vaginal stimulation, and rise in demand for minimally invasive or non-surgical products across the globe.

Get Report Sample @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=26612

High Prevalence of Urinary Incontinence and Overactive Bladder to Fuel Global Market Expansion

Urinary incontinence is one of the highly prevalent and largely underreported and under-diagnosed urological disorder worldwide, affecting millions of people having severe impact on physical, psychological as well as emotional health. Women are more affected than men and the incidence increases with age. Several factors such as weak pelvic floor muscles, urethral sphincters, obesity, pregnancy & childbirth, urinary tract infection, neurological disorders, and other related factors cause urinary incontinence. An estimated 200 million people across the globe are affected by some form of urinary incontinence or bladder problem. Stress urinary incontinence is the most common form affecting millions of people globally. Various studies suggest that 24% to 45% of women above 30 years suffer from stress urinary incontinence. Large number of patients with stress urinary incontinence and overactive bladder symptoms is projected to fuel the growth of the global urinary incontinence treatment devices market during the forecast period. 

Electrical Stimulation Devices to be Most Attractive Product Segment

The report offers detailed segmentation of the global urinary incontinence treatment devices market based on product, incontinence type, and end-user. In terms of product, the electrical stimulation devices segment is poised to account for leading share of the global market during the forecast period from 2017 to 2025. Factors attributed to the high share of the segment include rise in demand for minimally invasive/wearable and non-implantable electrical stimulation devices to strengthen the pelvic floor muscles, high success rates with electrical stimulation devices, and favorable medical reimbursement policies in developed countries for implantable electrical stimulation devices. Development and launch of new electrical stimulation devices for percutaneous tibial nerve stimulation for the treatment of overactive bladder (such as Medtronic plc’s NURO System) is projected to drive the segment during the forecast period. Moreover, recent launch of wearable electrical stimulation device INNOVO by Atlantic Therapeutics and rise in demand for FDA-approved over-the-counter electrical stimulation device by InControl Medical is estimated to propel the segment during the forecast period.

Urge Urinary Incontinence Segment Dominates the Market, Followed by Stress Urinary Incontinence

In terms of incontinence type, the urge incontinence segment is projected to dominate the global urinary incontinence treatment market during the forecast period. The segment is estimated to expand at a CAGR of 7.2% from 2017 to 2025. Millions of people across the globe are affected by overactive bladder leading to urge incontinence. Dominance of the urge incontinence segment is attributed to comparatively high cost of treatment devices for urge incontinence, especially implantable electrical stimulation devices, than other treatment devices/methods. Therefore, rise in incidence of urge incontinence, increase in adoption of electrical stimulation devices for overactive bladder treatment, and estimated new product launch in this segment is projected to contribute to the growth of the segment during the forecast period. 

Hospitals Segment Dominates the Market, Followed by Ambulatory Surgery Centers

In terms of end-user, the hospitals segment is projected to account for dominant share of the global urinary incontinence treatment devices market during the forecast period. The segment is likely to expand at a CAGR of 7.0% from 2017 to 2025. The ambulatory surgery centers segment is projected to account for the second leading share of the global urinary incontinence treatment devices market during the forecast period. High share of the segment is attributed to increase in number of surgical procedures for the treatment of all the types of urinary incontinence and favorable medical reimbursement policies for medical devices in most of the developed and developing countries. The home use segment is projected to expand at an exponential growth rate during the forecast period. Availability and high adoption of over-the-counter electrical stimulation and non-invasive treatment devices for effective management of urinary incontinence are the key factors driving the home use segment.

View Report @ https://www.transparencymarketresearch.com/urinary-incontinence-treatment-devices-market.html

Leave a Reply